PT Prodia Widyahusada TbkISX:PRDA -4.76%76 EV-to-FCF is 4.59 as of Jun. 30, 2026, which is 50% below its 10-year median of 9.27. GuruFocus rates ISX:PRDA with a GF Score™ of 76/100 and a GF Value™ of Rp3,124.34 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 97 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 91.75% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PT Prodia Widyahusada Tbk's Enterprise Value is Rp1,382,716 Mil.
PT Prodia Widyahusada Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was Rp300,991 Mil. Therefore, PT Prodia Widyahusada Tbk's EV-to-FCF for today is 4.59.
The historical rank and industry rank for PT Prodia Widyahusada Tbk's EV-to-FCF or its related term are showing as below:
ISX:PRDA'
s EV-to-FCF Range Over the Past 10 Years
Min: -373.9 Med: 9.27 Max: 256.23
Current: 4.89
During the past 13 years, the highest EV-to-FCF of PT Prodia Widyahusada Tbk was 256.23. The lowest was -373.90. And the median was 9.27.
ISX:PRDA's EV-to-FCF is ranked better than 91.75% of 97
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.8
vs ISX:PRDA: 4.89
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Prodia Widyahusada Tbk's PE Ratio (TTM) for today is calculated as:
PT Prodia Widyahusada Tbk's share price for today is Rp2400.00.
PT Prodia Widyahusada Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp237.646.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PT Prodia Widyahusada Tbk EV-to-FCF Related Terms
PT Prodia Widyahusada Tbk EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's EV-to-FCF falls into.
PT Prodia Widyahusada Tbk's current Enterprise Value is Rp1,382,716 Mil.
PT Prodia Widyahusada Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp300,991 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk (ISX:PRDA) has a EV-to-FCF of 4.59 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Prodia Widyahusada Tbk and its competitors. This is 50% below median its historical median of 9.27. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #8 out of 97 companies in the Medical Diagnostics & Research industry, placing it in the top 8.2%.
Is PT Prodia Widyahusada Tbk's EV-to-FCF too high?
PT Prodia Widyahusada Tbk's current EV-to-FCF of 4.59 is 50% below median its 10-year median of 9.27. The Medical Diagnostics & Research industry median EV-to-FCF is 22.80. PT Prodia Widyahusada Tbk's value of 4.59 is 79.9% below this industry median. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #8 out of 97 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #8 out of 97 companies for EV-to-FCF. This places PT Prodia Widyahusada Tbk in the top 8% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 22.80. PT Prodia Widyahusada Tbk's value of 4.59 is 79.9% below this benchmark. While the company's 10-year median is 9.27 vs. the industry median of 22.80, PT Prodia Widyahusada Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.80, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Prodia Widyahusada Tbk's current EV-to-FCF of 4.59 is 79.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current EV-to-FCF is 4.59, which is 50% below median its own 10-year median of 9.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk (ISX:PRDA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp3,124.34, compared to a current price of Rp2,400.00 — trading 23.2% below its estimated fair value. The current EV-to-FCF is 4.59, which is 50% below median its 10-year median of 9.27 and 79.9% below the Medical Diagnostics & Research industry median of 22.80. PT Prodia Widyahusada Tbk's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (ISX:PRDA), the current EV-to-FCF is 4.59 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Prodia Widyahusada Tbk (ISX:PRDA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk stock appears to be undervalued.
The current stock price of Rp2,400.00 is trading 23.2% below its estimated GF Value™ of Rp3,124.34.
GuruFocus considers PT Prodia Widyahusada Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRDA:
EV-to-FCF: 4.59 (50% below median its 10-year median of 9.27)
GF Value™: Rp3,124.34 vs. price of Rp2,400.00 (23.2% below fair value)
Industry Position: 79.9% below the Medical Diagnostics & Research median (#8 of 97)
No single metric tells the full story. See the ISX:PRDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
76GF Score
Get the complete analysis for ISX:PRDA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRDA has been successfully added to your 
